Feb 11, 2020: Bayer AG announced that it entered into a definitive agreement to transfer a large part of its Berlin-based small molecule research unit to Nuvisan, an international service provider for clinical studies, laboratory services and contract manufacturing with several sites and clinics in Germany and France.
The strategic partnership will arrange the foundation for a brand-new research entity to be established by the Nuvisan in Berlin. At the same time, it will support Bayer’s improved focus on the flexibility and productivity of its R&D operating model.
Financial terms were not disclosed.
The Berlin-based research unit with around 400 workplaces comprises of a fully operational team specialized in the small molecule research.
The research center comes with capabilities and capacities across the entire drug discovery value chain, including Lead Discovery, Medicinal Chemistry, Pharmacology, Drug Metabolism & Pharmacokinetics, Investigational Toxicology, and Animal Management.
Bayer will maintain significant research activities in the Berlin, which remains the headquarters for the company’s Pharmaceuticals Division and one of its major global research sites.
Bayer and Nuvisan will work together in the coming years to build the new research center. The transaction is expected to seal mid of 2020 subject to successful completion of the consultation process with the employee representatives and the preparations for succession the research activities.
The Nuvisan group creates sales of approx. € 55 million with currently about 420 highly qualified employees. It originated from the LAB GmbH over 40 years ago and has been operating under the name NUVISAN with its headquarters in Neu-Ulm since 2010.
The Nuvisan group as the CRO and CDMO has six sites in Germany and France (Neu-Ulm, Berlin, Grafing, Gauting, Waltrop and Sophia-Antipolis) in addition to the monitoring activities with offices in Argentina, Peru and Brazil as well as in the USA.
https://media.bayer.com/baynews/baynews.nsf/id/Bayer-and-Nuvisan-create-new-research-unit-in-Berlin
